SCOPE Detection Reagent
Antigen-based detection reagent specifically designed for monitoring CD20-targeting CAR T cells in B-cell malignancy research with robust specificity and reproducible performance.
The SCOPE CD20 Detection Reagent enables specific identification and quantification of CD20-targeting CAR-modified T cells in flow cytometry applications. CD20 is a well-established B-cell marker widely expressed in B-cell non-Hodgkin lymphomas and chronic lymphocytic leukemia, making it an important target for CAR T cell therapies.
This reagent detects the antigen-binding domain of CD20-directed CARs, providing a universal detection approach across different construct designs. The formulation is optimized for minimal background staining while maintaining high signal intensity for accurate CAR-positive cell enumeration.
The CD20 Detection Reagent shares the same validated manufacturing process and quality control standards as our CD19 and BCMA detection reagents, ensuring consistent performance across the SCOPE product line.
Designed for robust discrimination between CAR-positive and CAR-negative cells with minimal non-specific binding, enabling accurate quantification in complex sample matrices.
Manufacturing processes optimized for consistent performance across different reagent lots.
Compatible with standard flow cytometry staining protocols and common instrument configurations.
Works across different CD20 CAR construct designs, including various scFv orientations and generations.
Catalog Number
CD20534Custom kit sizes and bulk formats available upon request. Contact us for volume discounts and custom options.
Research Use Only (RUO): This product is intended for research use only and is not for use in diagnostic or therapeutic procedures.